Bitian Zhang

Ms. Bitian Zhang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BZBitian Zhang
Bitian Zhang
PLPing-Chung Leung
Ping-Chung Leung
CWChun-Kwok Wong
Chun-Kwok Wong
DWDJ WANG
DJ WANG
Glioma is a highly invasive brain cancer that is difficult to treat due to its complex molecular characteristics and poor prognosis. The COVID-19 pandemic has introduced additional clinical challenges for cancer patients, especially those with glioma. This study explored the molecular interactions between glioma and COVID-19 using integrated bioinformatics methods, including enrichment analysis, survival analysis, and molecular docking, focusing on the PI3K-Akt signaling pathway and the immunomodulatory role of vitamin D. From gene expression data of glioma and COVID-19, 203 common differentially expressed genes were identified, and six prognostic key genes—MYBL2, RBM6, VEPH1, AHNAK2, GNG10, and DUSP14—were further determined. After intersecting with vitamin D targets five prognostic key genes were determined—MYBL2, RBM6, VEPH1, AHNAK2 and GNG10. These genes play significant roles in the PI3K-Akt pathway and potentially interact with vitamin D. Molecular docking and single-cell RNA sequencing analyses suggest that vitamin D may improve the prognosis of glioma patients infected with COVID-19 by regulating these key genes and the PI3K-Akt pathway. The findings reveal molecular links between glioma and COVID-19, thereby providing new insights for developing targeted therapeutic strategies.

Verified
Journal Article
Open access
PDF file
DWDJ WANG
DJ WANG
BCBen C. L. Chan
Ben C. L. Chan
BZBitian Zhang
Bitian Zhang
KWKatie Ching-Yau Wong
Katie Ching-Yau Wong
LKLea Ling Yu Kan
Lea Ling Yu Kan
CWChun-Kwok Wong
Chun-Kwok Wong
Environmental pollutants are closely linked to lung cancer. The different types of environmental pollutants can be classified as chemical, physical, and biological. The roles of common chemical and physical pollutants such as PM2.5, smoking, radon, asbestos, and formaldehyde in lung cancer have been extensively studied. Notably, the worldwide COVID-19 pandemic raised awareness of the strong link between biological pollution and human health. Allergens such as house dust mites and pollen, as well as bacteria and viruses, are common biological pollutants. A few biological pollutants have been reported to promote lung cancer via inducing inflammatory cytokines secretion, such as IL-1β, IL-6, and TGF-β, as well as suppressing immunosurveillance by upregulating regulatory T (Treg) cells while dampening the function of CD8+ T cells and dendritic cells. However, the correlation between common biological hazards, such as SARS-CoV-2, human immunodeficiency viruses, Helicobacter pylori, and house dust mites, and lung cancer is not fully elucidated, and the underlying mechanisms are still unclear. Moreover, the majority of studies that have been performed in lung cancer and biological carcinogens were not based on the perspective of biological pollutants, which has challenged the systematicity and coherence in the field of biological pollutants in lung cancer. Here, in addition to reviewing the recent progress made in investigating the roles of allergens, viruses, and bacteria in lung cancer, we summarized the potential mechanisms underlying biological pollutants in lung cancer. Our narrative review can shed light on understanding the significance of biological pollutants in lung cancer, as well as inspire and broaden research ideas on lung cancer etiology.

2 July 2025 in International Journal of Surgery
Verified
Journal Article
Open access
BZBitian Zhang
Bitian Zhang
William C. ChoWilliam C. Cho
William C. Cho
PLPing-Chung Leung
Ping-Chung Leung
CWChun-Kwok Wong
Chun-Kwok Wong
DWDJ WANG
DJ WANG
Background: The membrane-spanning 4-domains subfamily A member 2 (MS4A2), a mast cell-specific IgE receptor component, exhibits paradoxical roles in cancer progression. While pan-cancer analyses suggest its context-dependent duality, its prognostic hierarchy across survival metrics – overall survival (OS), disease-specific survival (DSS), progression-free interval (PFI), and disease-free interval (DFI) – remains uncharacterized in lung adenocarcinoma (LUAD). Materials and methods: We integrated bulk RNA-seq (TCGA/GTEx, 33 cancers) and single-cell transcriptomics (NSCLC cohorts) to map MS4A2’s expression dynamics. Prognostic impacts were quantified through Cox regression and Kaplan–Meier modeling for all four survival endpoints (OS/DSS/PFI/DFI), complemented by immune infiltration and methylation-epigenetic correlation analyses. Drug sensitivity associations were evaluated using GDSC pharmacogenomics. Results: Pan-cancer stratification revealed LUAD-specific prognostic dominance of MS4A2, with elevated expression reducing mortality risk (OS HR = 0.58, DSS HR = 0.61; all P < 0.05) and prolonging disease control (PFI HR = 0.59, DFI HR = 0.59; all P < 0.05). Single-cell mapping localized MS4A2 to tumor-associated mast cells, where its bidirectional chemokine regulation – suppressing lymphoid homing (CCL19/CCL21) while amplifying myeloid recruitment (CCL20/CXCL8) – orchestrated leukocyte transendothelial migration. Clinically, MS4A2 exhibited female-biased expression ( P < 0.01) and stage-dependent attenuation ( P < 0.01), correlating with enhanced sensitivity to 5-fluorouracil and axitinib ( P < 0.05) in high-expressing tumors despite their immune-evasive traits. Conclusion: By converging multi-omics evidence across four prognostic axes (OS/DSS/PFI/DFI), we redefine MS4A2 as a mast cell-driven gatekeeper of LUAD progression. Its dual chemokine polarization establishes an immunosuppressive niche paradoxically susceptible to cytotoxic agents, proposing a precision stratification framework: MS4A2 high tumors for 5-FU/axitinib regimens combined with immunotherapies to counterbalance microenvironmental resistance. This quad-metric prognostic model advances LUAD management by linking mast cell biology to clinically actionable survival endpoints.

26 April 2025 in Cancers
Verified
Journal Article
Open access
PDF file
BZBitian Zhang
Bitian Zhang
XSXiaoyu Song
Xiaoyu Song
William C. ChoWilliam C. Cho
William C. Cho
CWChun-Kwok Wong
Chun-Kwok Wong
DWDJ WANG
DJ WANG
Objective: Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality, particularly in advanced stages. This study investigates the anticancer mechanisms of calycosin, an isoflavonoid derived from Astragalus membranaceus, in LUAD. Methods: Using integrative approaches including bulk and single-cell RNA sequencing, network pharmacology, and molecular docking, we identified SMAD3 as a critical biomarker associated with LUAD staging and prognosis. Results: Calycosin targets SMAD3, modulating the NOTCH signaling pathway in monocytes/macrophages to suppress tumor growth, invasion, and immune evasion. Enrichment analyses revealed significant involvement of NOTCH signaling components in SMAD3-correlated genes, particularly in advanced-stage LUAD. Single-cell RNA sequencing further demonstrated NOTCH pathway enrichment in tumor-associated monocytes/macrophages. Additionally, KMT2A was identified as a key transcriptional regulator in these cells. Conclusions: These findings highlight the potential effects of calycosin and provide novel insights into targeting the tumor–immune microenvironment in LUAD.